Inhibition of hepatitis C virus RNA replication by 2'-modified nucleoside analogs (Q40674388)

22 September 2017

Inhibition of hepatitis C virus RNA replication by 2'-modified nucleoside analogs (English)

1 reference

22 September 2017

1 reference

Raffaele De Francesco

object named as

Raffaele De Francesco

15

0 references

author name string

Steven S Carroll

1

1 reference

22 September 2017

Joanne E Tomassini

2

1 reference

22 September 2017

Michele Bosserman

3

1 reference

22 September 2017

Krista Getty

4

1 reference

22 September 2017

Mark W Stahlhut

5

1 reference

22 September 2017

Anne B Eldrup

6

1 reference

22 September 2017

Balkrishen Bhat

7

1 reference

22 September 2017

Dawn Hall

8

1 reference

22 September 2017

Amy L Simcoe

9

1 reference

22 September 2017

Robert LaFemina

10

1 reference

22 September 2017

Carrie A Rutkowski

11

1 reference

22 September 2017

Bohdan Wolanski

12

1 reference

22 September 2017

Zhucheng Yang

13

1 reference

22 September 2017

Giovanni Migliaccio

14

1 reference

22 September 2017

Lawrence C Kuo

16

1 reference

22 September 2017

Malcolm MacCoss

17

1 reference

22 September 2017

David B Olsen

18

1 reference

22 September 2017

language of work or name

English

0 references

publication date

27 January 2003

1 reference

Journal of Biological Chemistry

22 September 2017

1 reference

22 September 2017

278

1 reference

22 September 2017

14

1 reference

22 September 2017

11979-11984

1 reference

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome

22 September 2017

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210914200

An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210914200

The prevalence of hepatitis C virus infection in the United States, 1988 through 1994

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210914200

Clinical outcomes after transfusion-associated hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210914200

Mortality from liver cancer and liver disease in haemophilic men and boys in UK given blood products contaminated with hepatitis C. UK Haemophilia Centre Directors' Organisation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210914200

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210914200

Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (I

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210914200

Peginterferon alfa-2a in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210914200

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210914200

Antiviral drugs: current state of the art.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210914200

RNA-dependent RNA polymerase of hepatitis C virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210914200

A novel mechanism to ensure terminal initiation by hepatitis C virus NS5B polymerase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210914200

De novo initiation of RNA synthesis by the RNA-dependent RNA polymerase (NS5B) of hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210914200

Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210914200

Efficient initiation of HCV RNA replication in cell culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210914200

Effect of alpha interferon on the hepatitis C virus replicon

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210914200

2'-C-Methyl analogues of selective adenosine receptor agonists: synthesis and binding studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210914200

Syntheses of nucleoside triphosphates

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210914200

Only a small fraction of purified hepatitis C RNA-dependent RNA polymerase is catalytically competent: implications for viral replication and in vitro assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210914200

Crystal structure of the RNA-dependent RNA polymerase of hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210914200

Elementary steps in the DNA polymerase I reaction pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210914200

CNS-Specific Ribozyme Expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210914200

Purification of mammalian DNA polymerases: DNA polymerase alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210914200

Hepatitis C virus nonstructural proteins are localized in a modified endoplasmic reticulum of cells expressing viral subgenomic replicons

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210914200

21 January 2018

Identifiers

DOI

10.1074/JBC.M210914200

1 reference

22 September 2017

1 reference